Lotte New York Palace Hotel

Venus Concept Inc. to Present at the H.C. Wainwright 25th Annual Global Investment Conference

Retrieved on: 
Wednesday, September 6, 2023
Venus, Webcast, Conference, Lotte New York Palace Hotel, Nightclub

TORONTO, Sept. 06, 2023 (GLOBE NEWSWIRE) -- Venus Concept Inc. (“Venus Concept” or the “Company”) (NASDAQ: VERO), a global medical aesthetic technology leader, today announced that management will participate in the H.C. Wainwright 25th Annual Global Investment Conference, which is being held virtually and in person at the Lotte New York Palace in New York, NY from September 11th-13th.

Key Points: 
  • TORONTO, Sept. 06, 2023 (GLOBE NEWSWIRE) -- Venus Concept Inc. (“Venus Concept” or the “Company”) (NASDAQ: VERO), a global medical aesthetic technology leader, today announced that management will participate in the H.C. Wainwright 25th Annual Global Investment Conference, which is being held virtually and in person at the Lotte New York Palace in New York, NY from September 11th-13th.
  • Management’s presentation will be available on demand beginning on Monday, September 11th at 7:00 a.m. Eastern Time.
  • An audio webcast of the presentation will be accessible under the “Events” section of the Company's investor relations website at https://ir.venusconcept.com/ .
  • An archive of the webcast will be available for replay following the conference.

Spero Therapeutics to Present at H.C. Wainwright 25th Annual Global Investment Conference

Retrieved on: 
Wednesday, September 6, 2023
Webcast, Lotte New York Palace Hotel, Infection, MDR, Rare, Spero, Therapy, Conference, Pharmaceutical industry, Online shopping

CAMBRIDGE, Mass., Sept. 06, 2023 (GLOBE NEWSWIRE) -- Spero Therapeutics, Inc. (Nasdaq: SPRO) (Spero), a multi-asset clinical-stage biopharmaceutical company, focused on identifying, developing and commercializing treatments in high unmet need areas involving rare diseases and multi-drug resistant (MDR) bacterial infections, today announced that Sath Shukla, President and Chief Executive Officer of Spero Therapeutics, will present and be available for one-on-one meetings at the H.C. Wainwright 25th Annual Global Investment Conference, which is taking place September 11-13, 2023, at the Lotte New York Palace Hotel in New York, NY.

Key Points: 
  • CAMBRIDGE, Mass., Sept. 06, 2023 (GLOBE NEWSWIRE) -- Spero Therapeutics, Inc. (Nasdaq: SPRO) (Spero), a multi-asset clinical-stage biopharmaceutical company, focused on identifying, developing and commercializing treatments in high unmet need areas involving rare diseases and multi-drug resistant (MDR) bacterial infections, today announced that Sath Shukla, President and Chief Executive Officer of Spero Therapeutics, will present and be available for one-on-one meetings at the H.C. Wainwright 25th Annual Global Investment Conference, which is taking place September 11-13, 2023, at the Lotte New York Palace Hotel in New York, NY.
  • Details are as follows:
    The webcast may also be accessed through Spero Therapeutics’ website ( www.sperotherapeutics.com ) on the “Events and Presentations” page under the “Connect” tab.
  • Replays will be available on the website following the conclusion of each event.

Phio CEO to Speak at Wainwright Conference in New York in September

Retrieved on: 
Wednesday, September 6, 2023
Lotte New York Palace Hotel, Phio Pharmaceuticals, FDA, EST, Conference, Pharmaceutical industry

Mr. Bitterman will discuss the recent FDA IND approvals for Phio’s lead product, PH-762; PH-762 is currently cleared for two clinical trials.

Key Points: 
  • Mr. Bitterman will discuss the recent FDA IND approvals for Phio’s lead product, PH-762; PH-762 is currently cleared for two clinical trials.
  • Mr. Bitterman will also review the Company’s evolution from discovery to development, highlighting the new, industry-experienced leadership team he has put in place to lead this transformation.
  • The presentation will become available online at 7:00 am EST on Monday, September 11th.
  • The Conference will be taking place September 11th—13th at the Lotte New York Palace Hotel in New York City.

Indaptus Therapeutics to Present at the H.C. Wainwright 25th Annual Global Investment Conference

Retrieved on: 
Wednesday, September 6, 2023
Lotte New York Palace Hotel, Therapy, Conference, Cryptocurrency, Hotel

NEW YORK, Sept. 06, 2023 (GLOBE NEWSWIRE) -- Indaptus Therapeutics, Inc. (Nasdaq: INDP) announced today that Jeffrey A. Meckler, Chief Executive Officer, will present a corporate overview at the H.C. Wainwright 25th Annual Global Investment Conference.

Key Points: 
  • NEW YORK, Sept. 06, 2023 (GLOBE NEWSWIRE) -- Indaptus Therapeutics, Inc. (Nasdaq: INDP) announced today that Jeffrey A. Meckler, Chief Executive Officer, will present a corporate overview at the H.C. Wainwright 25th Annual Global Investment Conference.
  • The conference is being held on September 11 – 13, 2023 at the Lotte New York Palace Hotel.

Lightning eMotors to Present at the H.C. Wainwright 25th Annual Global Investment Conference on September 12

Retrieved on: 
Wednesday, September 6, 2023
Automotive Manufacturing, Alternative Energy, Energy, Manufacturing, Alternative Vehicles, Fuels, Technology, Other Automotive, EV, Electric Vehicles, Batteries, Performance & Special Interest, Trucking, Fleet Management, General Automotive, Transport, Automotive, Engineering, ZEV, Lotte New York Palace Hotel, Conference, NYSE, Cryptocurrency, Hotel

Lightning eMotors, Inc. (NYSE: ZEV), a leading provider of zero emission medium-duty commercial vehicles and electric vehicle technology for fleets, today announced that the Company’s CEO, Tim Reeser, will present at the H.C. Wainwright 25th Annual Global Investment Conference on September 12.

Key Points: 
  • Lightning eMotors, Inc. (NYSE: ZEV), a leading provider of zero emission medium-duty commercial vehicles and electric vehicle technology for fleets, today announced that the Company’s CEO, Tim Reeser, will present at the H.C. Wainwright 25th Annual Global Investment Conference on September 12.
  • Where: Lotte New York Palace Hotel, New York, NY

Oncolytics Biotech® to Participate in a Fireside Chat at the H.C. Wainwright 25th Annual Global Investment Conference

Retrieved on: 
Wednesday, September 6, 2023
Oncolytics Biotech, AB, ONC, SAN, Lotte New York Palace Hotel, TSX, Conference, LINK, Cryptocurrency

SAN DIEGO and CALGARY, AB, Sept. 6, 2023 /PRNewswire/ -- Oncolytics Biotech® Inc. (NASDAQ: ONCY) (TSX: ONC) today announced that Chief Executive Officer Dr. Matt Coffey will participate in a fireside chat at the H.C. Wainwright 25th Annual Global Investment Conference, which is taking place September 11-13, 2023 at the Lotte New York Palace Hotel in New York, NY.

Key Points: 
  • SAN DIEGO and CALGARY, AB, Sept. 6, 2023 /PRNewswire/ -- Oncolytics Biotech® Inc. (NASDAQ: ONCY) (TSX: ONC) today announced that Chief Executive Officer Dr. Matt Coffey will participate in a fireside chat at the H.C. Wainwright 25th Annual Global Investment Conference, which is taking place September 11-13, 2023 at the Lotte New York Palace Hotel in New York, NY.
  • Additional details on the fireside chat can be found below.
  • Company management will also be participating in one-on-one investor meetings at the conference.
  • To schedule a meeting, please submit a request on the conference website, contact your H.C. Wainwright representative, or email [email protected] .

Oncolytics Biotech® to Participate in a Fireside Chat at the H.C. Wainwright 25th Annual Global Investment Conference

Retrieved on: 
Wednesday, September 6, 2023
Oncolytics Biotech, AB, ONC, SAN, Lotte New York Palace Hotel, TSX, Conference, LINK, Cryptocurrency

SAN DIEGO and CALGARY, AB, Sept. 6, 2023 /PRNewswire/ -- Oncolytics Biotech® Inc. (NASDAQ: ONCY) (TSX: ONC) today announced that Chief Executive Officer Dr. Matt Coffey will participate in a fireside chat at the H.C. Wainwright 25th Annual Global Investment Conference, which is taking place September 11-13, 2023 at the Lotte New York Palace Hotel in New York, NY.

Key Points: 
  • SAN DIEGO and CALGARY, AB, Sept. 6, 2023 /PRNewswire/ -- Oncolytics Biotech® Inc. (NASDAQ: ONCY) (TSX: ONC) today announced that Chief Executive Officer Dr. Matt Coffey will participate in a fireside chat at the H.C. Wainwright 25th Annual Global Investment Conference, which is taking place September 11-13, 2023 at the Lotte New York Palace Hotel in New York, NY.
  • Additional details on the fireside chat can be found below.
  • Company management will also be participating in one-on-one investor meetings at the conference.
  • To schedule a meeting, please submit a request on the conference website, contact your H.C. Wainwright representative, or email [email protected] .

Apollomics to Present at the H.C. Wainwright 25th Annual Global Investment Conference

Retrieved on: 
Wednesday, September 6, 2023
Entrepreneurship, Conference, Lotte New York Palace Hotel, Pharmaceutical industry, Cryptocurrency

FOSTER CITY, Calif., Sept. 06, 2023 (GLOBE NEWSWIRE) -- Apollomics Inc. (“Apollomics” or the “Company”), a clinical-stage biopharmaceutical company developing multiple oncology drug candidates to address difficult-to-treat and treatment-resistant cancers, today announced that Sanjeev Redkar, Ph.D., Co-Founder, Executive Director and President, will present at the H.C. Wainwright 25th Annual Global Investment Conference on Wednesday, September 13, 2023 at 10:30 a.m.

Key Points: 
  • FOSTER CITY, Calif., Sept. 06, 2023 (GLOBE NEWSWIRE) -- Apollomics Inc. (“Apollomics” or the “Company”), a clinical-stage biopharmaceutical company developing multiple oncology drug candidates to address difficult-to-treat and treatment-resistant cancers, today announced that Sanjeev Redkar, Ph.D., Co-Founder, Executive Director and President, will present at the H.C. Wainwright 25th Annual Global Investment Conference on Wednesday, September 13, 2023 at 10:30 a.m.
  • ET at the Lotte New York Palace in New York, NY.
  • Investors interested in arranging a meeting with the Company’s management during the conference should contact the H.C. Wainwright conference coordinator.
  • An audio webcast link of the presentation will be accessible, and an archived replay of the presentation will be available for 90 days following the event, under the Investors tab of the Apollomics website at https://www.apollomicsinc.com .

Protalix BioTherapeutics to Present at the H.C. Wainwright 25th Annual Global Investment Conference

Retrieved on: 
Wednesday, September 6, 2023
Bashan, Lotte New York Palace Hotel, Conference, NYSE, Protalix BioTherapeutics, EDT, Fine chemical, Security (finance), Hotel

CARMIEL, Israel, Sept. 6, 2023 /PRNewswire/ -- Protalix BioTherapeutics, Inc. (NYSE American: PLX), a biopharmaceutical company focused on the development, production and commercialization of recombinant therapeutic proteins produced by its proprietary ProCellEx® plant cell–based protein expression system, today announced that Dror Bashan, the Company's President and Chief Executive Officer, will present on Wednesday, September 13, 2023 at 3:00 p.m. Eastern Daylight Time (EDT) at the H.C. Wainwright 25th Annual Global Investment Conference.

Key Points: 
  • CARMIEL, Israel, Sept. 6, 2023 /PRNewswire/ -- Protalix BioTherapeutics, Inc. (NYSE American: PLX), a biopharmaceutical company focused on the development, production and commercialization of recombinant therapeutic proteins produced by its proprietary ProCellEx® plant cell–based protein expression system, today announced that Dror Bashan, the Company's President and Chief Executive Officer, will present on Wednesday, September 13, 2023 at 3:00 p.m. Eastern Daylight Time (EDT) at the H.C. Wainwright 25th Annual Global Investment Conference.
  • The conference is being held on September 11-13, 2023 at the Lotte New York Palace Hotel, New York City, NY.
  • Mr. Bashan will provide a live corporate overview at the conference, and will participate in one-on-one meetings with investors who are registered to attend the conference.

Super League Announces Participation in the H.C. Wainwright 25th Annual Global Investment Conference

Retrieved on: 
Tuesday, September 5, 2023
SLGG, Super League, Lotte New York Palace Hotel, Conference, Tourism, Cryptocurrency, Video game

SANTA MONICA, Calif., Sept. 05, 2023 (GLOBE NEWSWIRE) -- Super League (Nasdaq: SLGG), a global leader in providing immersive experiences across the world's largest metaverse gaming platforms, today announced management’s participation in the H.C. Wainwright 25th Annual Global Investment Conference being held September 11-13 virtually and at the Lotte New York Palace Hotel in New York City.

Key Points: 
  • SANTA MONICA, Calif., Sept. 05, 2023 (GLOBE NEWSWIRE) -- Super League (Nasdaq: SLGG), a global leader in providing immersive experiences across the world's largest metaverse gaming platforms, today announced management’s participation in the H.C. Wainwright 25th Annual Global Investment Conference being held September 11-13 virtually and at the Lotte New York Palace Hotel in New York City.
  • The Company’s Chief Executive Officer, Ann Hand, and Chief Financial Officer, Clayton Haynes, will be available for virtual one-on-one meetings with investors.
  • To schedule a meeting with Super League’s management, please contact your conference representative or you may also email your request to [email protected].
  • To register for the conference, please contact your H.C. Wainwright representative or visit the conference website here .